H35.51
Vitreoretinal dystrophy
Clinical Classification Guidelines
Medical Intelligence & Overview
Vitreoretinal dystrophy is a group of eye disorders affecting the vitreous humor and retina, the light-sensitive layer at the back of the eye. This condition can lead to visual impairment if not monitored or managed properly. Often inherited, vitreoretinal dystrophies can vary in severity and presentation, sometimes progressing over time. Recognizing the signs early and understanding the causes can help in planning appropriate care to preserve eye health.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents Autosomal dominant or recessive inheritance patterns Certain syndromes associated with retinal dystrophies Age-related degenerative changes (less common in hereditary forms) Trauma or injury affecting the eye Underlying systemic conditions that impact retinal health
Key Symptoms: Gradual or sudden loss of vision Floaters or spots in the visual field Visual distortions, such as straight lines appearing wavy Reduced visual acuity or clarity Difficulty adapting to low light or darkness Color vision changes in some cases Peripheral vision loss in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye exam by an ophthalmologist, including detailed retinal examination using tools like slit-lamp biomicroscopy and ophthalmoscopy. Advanced imaging techniques such as optical coherence tomography (OCT) and fluorescein angiography help visualize retinal layers and detect abnormalities. Genetic testing may also be recommended, especially if hereditary factors are suspected, to identify specific mutations associated with vitreoretinal dystrophies.
Treatment Protocols: While there is no cure for vitreoretinal dystrophy, management focuses on monitoring and preventing progression. Possible approaches include: - Regular eye examinations to detect changes early - Laser therapy or surgeries like vitrectomy in cases with complications such as retinal detachment or severe vitreous hemorrhage - Use of low-vision aids to enhance remaining vision - Counseling and support for hereditary aspects, including genetic counseling Research is ongoing to develop targeted therapies, but current strategies aim to preserve sight and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is H35.51 a billable ICD-10 code?
Yes, H35.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.51?
Clinical documentation must specify the nature of Vitreoretinal dystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference